- Develop the overall US and ROW regulatory strategy for development programs
- Lead and manage health authority relationships, communications, and negotiations
- Maintain current CE Mark in EU
- Provide strategic regulatory leadership, guidance, and training for all clinical development
- Lead regulatory risk assessment and mitigation
- Lead the regulatory function on cross functional development teams and ensure that all are
- Ensure that all components of manufacturing and quality programs relevant to the CMC
- Manage and communicate regulatory expectations to vendors (CROs, CMOs, consultants,
- Plan, participate in, and review submissions to regulatory authorities including FDA, EU and
- Prepare meeting requests, briefing documents, coordinate and prepare teams for meetings,
- Provide interpretation of and advice regarding regulations, directives, and guidance
- Hire, train, and manage regulatory affairs department (currently six staff)
- Extensive senior level experience in regulatory affairs
- People management experience
- Experience with having led the regulatory aspects of an oncology product, through
- Knowledge of US FDA drug regulations
- Experience with FDA, MDR, and ICH guidelines both strategically and operationally including
- Experience leading regulatory aspects of late stage drug development through to market
- Demonstrated experience and expertise in preparing complex regulatory documents
- Regulatory Affairs certification (RAC) in US and EU (strongly preferred)
- Experience of interacting directly with the FDA, i.
- Large pharma and biotechnology company experience
- Experience with first in class drugs
- Experience with injectables
- Understanding of EU device regulations
- Advanced degree
- Proven leadership skills in a growing global company environment
- Entrepreneurial, with a willingness to challenge the status quo
- Strong interpersonal skills to quickly gain confidence both with internal stakeholders and
- Able to contribute beyond their functional expertise to build a successful oncology company
- Creative and agile with a hands on approach
- Able to work with some level of ambiguity, i.
- Driven by a need to help all patients who may benefit from Nanobiotix's technology and
- Interested in the greater good of assisting patients in need
- Competitive base salary
- Performance related bonus
- Relocation assistance, where required
-
VP, Regulatory Affairs
1 week ago
Vigilneuro Oklahoma City, United StatesVigil Neuroscience is the world's first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain's immune system. We are utilizing the tools of mo ...
-
Regulatory Affairs Consultant
1 week ago
Connect Life Science Oklahoma City, United StatesRegulatory Affairs Consultant · Cambridge MA, Remote with occasional site time · Medical Device · 6 month contract - 40 hours per week · Competitve hourly rate · A MedTech company based in Massachusetts specializing in Class 2 Medical Device solutions are looking to hire a contr ...
-
Manager, Regulatory Affairs
1 week ago
The AES Corporation Oklahoma City, United StatesAt AES, we raise the quality of life around the world by changing the way energy works. Everyone makes an impact every day in our small, global teams. Apply here to start an extraordinary career today. · AES Clean Energy, a subsidiary of The AES Corporation global company, speci ...
-
Regulatory Affairs Specialist III
1 week ago
Paragonix Technologies, Inc. Oklahoma City, United StatesParagonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unpreced ...
-
Director Regulatory Affairs-CMC
1 week ago
Disc Medicine Oklahoma City, United StatesDisc Medicine is seeking a Director, Regulatory Affairs-CMC to serve as the Regulatory-CMC lead for Disc Medicine's small molecule program pipeline. This position will have close collaboration with the development teams and visibility to the executive leadership with meaningful o ...
-
Sr Director, Regulatory Affairs
1 week ago
HireMinds Oklahoma City, United StatesOur cutting-edge, vaccine client is seeking a · Sr. Director, Regulatory Affairs · (REMOTE) to their growing team This role will be accountable for developing regulatory strategies for their vaccine candidates with an emphasis on European requirements for early and late-stage a ...
-
Head, Global Regulatory Affairs
1 week ago
Corbus Pharmaceuticals Oklahoma City, United StatesOur passion. Our purpose. At Corbus, it starts at our core. · We look for unique talent. Our people are brilliant, they break barriers and are not defined by a title. Eclectic experiences make Corbus a special place to share ideas and grow. At Corbus, transformative ideas can com ...
-
Director/Senior Director Regulatory Affairs
1 week ago
ScientaSearch Limited Oklahoma City, United StatesA clinical-stage biotech focused on Rare Diseases. This company utilizes antibodies to harness the bodies immune system to fight off disease. · The Role · This person ill serve as the GRL for the company's early stage proprietary pipeline as well as supporting partnered programs ...
-
Senior Manager Regional Regulatory Affairs
1 week ago
CSL Plasma Oklahoma City, United StatesSenior Manager Regional Regulatory Affairs page is loaded · Senior Manager Regional Regulatory Affairs · Apply · locations · Americas, US-PA, King of Prussia, CSL Behring · time type · Full time · posted on · Posted 2 Days Ago · job requisition id · R · CSL Behring is ...
-
Manager/Sr. Manager, Regulatory Affairs CMC
1 week ago
X4lifesciences Oklahoma City, United StatesX4 Life Sciences are working with a cutting-edge biologics manufacturer in the oncology and autoimmune disease space, who are looking to bring on board a Regulatory Affairs CMC Manager / Senior Manager to support global regulatory submission projects and be hands-on in the prepar ...
-
EPM Scientific Oklahoma City, United StatesTitle: · Associate Director, Regulatory Affairs Advertising & Promotion · The Associate Director, Regulatory Affairs Advertising & Promotion will be responsible for providing strategic, operational and tactical regulatory advice to internal stakeholders regarding communications ...
-
Corbus Pharmaceuticals Oklahoma City, United StatesSenior Director/Director, Global Regulatory Affairs · Full-time · Our passion. Our purpose. At Corbus, it starts at our core. · We look for unique talent. Our people are brilliant, they break barriers and are not defined by a title. Eclectic experiences make Corbus a special pla ...
-
Executive Director, Medical Affairs
1 week ago
Morphic Therapeutic Oklahoma City, United StatesAbout Morphic Therapeutic · Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. In collaboration ...
-
Sr. MSL II, Glaucoma and Retina
1 week ago
AbbVie Oklahoma City, United StatesCompany Description · AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas ...
-
Sr. MSL II, Glaucoma and Retina
1 week ago
BioSpace Oklahoma City, United StatesJob Details · Company Description · AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key the ...
-
Director of Quality
1 week ago
Molecular Search Oklahoma City, United StatesMolecular Search is proud to collaborate with a premier CDMO specializing in drug product development and manufacturing. Our client is dedicated to delivering high-quality pharmaceutical solutions to enhance patient health and well-being. · Responsibilities: · Lead the developme ...
-
Tower Riggers
5 days ago
TrueNet Oklahoma City, United StatesJob Type: Full-time, Permanent · COMsolve is looking for keen, punctual general laborers and riggers, eager to learn and advance their careers. COMsolve's industry-leading training course will provide all the knowledge and tools needed to work on a crew installing and maintaining ...
-
Associate Director, Global Labeling
1 week ago
Takeda Oklahoma City, United StatesBy clicking the "Apply" button, I understand that my employment application process with Takeda will commence and that · the information I provide in my application will be processed in line with · Takeda's · Privacy Notice · and · Terms of Use . · I further attest that all ...
-
Clarivate Oklahoma City, United StatesClarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. Our connected data, deep expert ...
-
Medical Director
2 weeks ago
Avetix Group Oklahoma City, United StatesAbout the position · We are looking for a (Senior) Medical Director, Oncology TA Head to lead and oversee the medical strategy for the oncology therapeutic area. You will play a crucial role in the development and implementation of clinical programs and provide medical expertise ...
senior vice president or vice president, global regulatory affairs - Oklahoma City, United States - ACIP
Description
Nanobiotix – a brief historyEst.
2003, Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use proprietary nanotechnology to transform cancer treatment.
Headquartered in Paris (c.70 staff) and with a US affiliate in Cambridge, MA (c.20 staff),Nanobiotix designs and manufactures nanoparticles that safely enhance the efficacy of radiation
therapy. With this approach, their ambition is to benefit millions of patients who receive
radiation therapy by improving the efficiency of radiation in tumor cells without increasing the
dose received by surrounding healthy tissues. Their belief is that radiotherapy combined with
NBTXR3 can become a new standard of care in the treatment of cancer.
Nanobiotix first received authorization to start the pilot phase I/II clinical study in humans in
2011, when they began also the treatment of the first patient. Filing of the CE Marking
Application for NBTXR3 in Soft Tissue Sarcoma came in 2017, followed by positive phase II/III
results for NBTXR3 in Soft Tissue Sarcoma. European market approval for NBTXR3 in this
indication was achieved in 2019 however, Nanobiotix Investors made the strategic decision to
place commercialization strategies 'on hold' and to instead, accelerate the global development of
NBTXR3 for 'head and neck', i.e. as a drug, both in Europe and the US.
Nanobiotix were publicly listed on the Nasdaq stock exchange in 2020 – a total raise of
S$113.3million.
Nanobiotix – NBTXR3 Mode of Action
NBTXR3 is being evaluated both as a single agent activated by radiotherapy alone, and as a
combination product with other anti-cancer therapies including chemotherapy and immune
checkpoint inhibitors. Once injected into the tumor, nanoparticles developed by Nanobiotix are
designed to accumulate in cancer cells in clusters while remaining inert thanks to their specific
size and their negatively-charged particular coating.
The principle of action is based on the interaction of the high electron density nanoparticles and
ionizing radiation (e.g. radiotherapy) to locally generate photons and secondary electrons within
the cell and subsequent radical production. The energy released from these clusters of
nanoparticles constitutes a dose deposit "hotspot," which should lead to high, localized
destruction of biological subcellular structures and increased cell death.
Ionizing radiation can be applied to the nanoparticles repeatedly because they return to their
inactive, inert state after each exposure to radiation. Multiple courses of radiotherapy can be
administered to a tumor that has received a single injection of the nanoparticles.
In preclinical studies, the radiation-activated nanoparticles have also been observed to trigger
metastatic cell destruction due to immunogenic cell death, leading to activation of the immune
system. Based on these observations Nanobiotix believe that their nanoparticles may prime the
body's immune response, rendering tumors more prone to recognition by a patient's immune
system.
Nanobiotix have launched multiple Phase I/II trials including a large clinical collaboration with
MD Anderson Cancer Center for 9 clinicals trials in six cancers types (head and neck, pancreatic,
thoracic, lung, gastrointestinal and genitourinary cancers).
In 2020 they were granted Fast Track designation by the FDA for investigation of NBTXR3 in head
and neck cancer. Phase I results were particularly positive, such that fast-track designation was
granted. In November 2021 Nanobiotix began its global phase III registration study for NBTXR3 in
'head and neck', in the US. In partnership with a global CRO, recruitment of patients shall be
taking place at 110 sites.
MD Anderson Cancer Center are helping with the expansion of use of NBTXR3 in other immuno-oncology indications. Following previously reported preliminary data demonstrating the ability of
the NBTXR3 to help transform anti-PD-1 non-responders into responders, Nanobiotix is
expanding its immuno-oncology phase I basket study evaluating its product in combination with
anti-PD-1 checkpoint inhibitors. A proposed protocol pathway for immuno-oncology will be
finalised and submitted to the FDA during quarter With phase III clinical trials for NBTXR3 in 'head and neck' now underway, Nanobiotix have
reached a point in its inflection where the appointment of a Global Head of Regulatory Affairs is
required at SVP or VP level, i.e. a highly visible core member of the Strategic Leadership Team
who raises the profile of function internally.
Reporting to the CEO the SVP/VP Global Regulatory Affairs drives the articulation and
implementation of a Global regulatory strategy with an emphasis on US and EU, management of
resources, regulatory timelines, representation with regulatory authorities, regulatory
compliance, and adherence to guidelines throughout the development and regulatory life cycle.
(S)he is a strategic partner to the CEO on designing, articulating, and shaping global regulatory
strategy. Required is a 'thought partner', someone who contributes beyond their functional area
of expertise to educate and to develop capabilities across R&D. This includes wider cultural
questions, such as helping employees understand 'what is at stake' (i.e. for a biotechnology
company that is running global phase III clinical trials), and on what is needed to be done to build
a successful oncology company.
In the short-to-mid term the SVP/VP Global Regulatory Affairs primary focus shall be the
evaluation of trials currently underway, so as to devise a global regulatory strategy for
Nanobiotix. In addition, to oversee the implementation of the phase III programme, including the
anticipation of requirements for inspections.
*For candidates of appropriate skills/experience the role may be broadened to include management
of QA
JOB DESCRIPTION
Key responsibilities:
portfolio and ensure accuracy, and provide sign-off on all documents presented to
regulatory agencies
information
CANDIDATE SPECIFICATION
Essential:
Preferred:
complex concepts
Important Attributes:
complex regulatory components
on an ongoing basis
The salary and terms of employment will be discussed in detail at an appropriate stage of an
interview with Nanobiotix. The following should serve as a guide only
#J-18808-Ljbffr